Feasibility and Safety of Ultrasound Guided Installation Central Subclavian Catheter Through Supraclavicular Way
NCT ID: NCT02809664
Last Updated: 2017-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2015-10-14
2017-11-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Subclavian Vein Ultrasound Guided Cannulation in Adult
NCT00882297
Short-axis/out-of-plane Approach Versus Oblique- Axis Approach for US Guided IJV Catheterization in Infants.
NCT06652490
Wireless US-guided CVC Placement in Infants
NCT04597021
SUBclavian Central Venous Catheters Guidance and Examination by UltraSound
NCT01888094
Comparison of Axillary Versus Subclavian Vein Strategies for Central Venous Catheterization Under Continuous Ultrasound Guidance
NCT01543360
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All infants less than 44 weeks corrected age who require a surgical approach
* In the first line if neonate over 34 weeks corrected age requiring dual carriageway catheter
* After Failure or inability laying KTEC for children between 30 and 34 weeks of age corrected and heavy over 1000
Exclusion Criteria
* Nouveau-né de moins de 30 semaines d'âge corrigé
* Choix d'une autre voie d'abord plus judicieux (KTVO, KTC broviac)
* Sortie avant retrait du KTC
43 Weeks
44 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre Kuhn, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Strasbourg, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de réanimation néonatale - HOPITAL DE HAUTEPIERRE
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6287
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.